In conclusion, this is the first report demonstrating that DHX32 promotes cell proliferation, migration, and invasion, as well as reduces sensitivity to chemotherapy reagents in CRC, via modulating expressions of gene involved in cancer cell growth, migration, and survival. The gene discussed is DHX32; the disease is cancer.